Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-07 Sale |
2025-03-11 4:32 pm |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
100 | $30 | $3,000 | 394,807 (Indirect Direct) |
View |
2025-02-05 Sale |
2025-02-07 4:38 pm |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
9,536 | $30.13 | $287,316 | 437,452 (Indirect Direct) |
View |
2024-05-02 Sale |
2024-05-03 6:26 pm |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
3,152 | $18.91 | $59,604 | 363,679 (Indirect Direct) |
View |
2023-05-02 Sale |
2023-05-03 6:25 pm |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
3,203 | $8.9049 | $28,522 | 366,831 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-07 Exercise |
2025-03-11 4:32 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
100 | $0.18 | 394,807 (Direct) |
View |
2025-03-07 Exercise |
2025-03-11 4:32 pm |
2021-06-13 2027-08-08 |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
100 | $0 | 394,807 (Direct) |
View |
2025-02-05 Exercise |
2025-02-07 4:38 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
8,636 | $0.18 | 437,452 (Direct) |
View |
2025-02-06 Exercise |
2025-02-07 4:38 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
900 | $13.11 | 437,452 (Direct) |
View |
2025-02-05 Exercise |
2025-02-07 4:38 pm |
2021-06-13 2027-08-08 |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
9,536 | $0 | 437,452 (Direct) |
View |
2024-08-12 Option Award |
2024-08-14 4:14 pm |
N/A 2034-08-12 |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
503,125 | $0 | 503,125 (Direct) |
View |
2024-05-01 Exercise |
2024-05-03 6:26 pm |
N/A 2032-05-01 |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
10,417 | $0 | 363,679 (Direct) |
View |
2023-08-17 Option Award |
2023-08-18 7:12 pm |
N/A 2033-08-17 |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
600,000 | $0 | 600,000 (Direct) |
View |
2023-05-01 Exercise |
2023-05-03 6:25 pm |
N/A 2032-05-01 |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
10,416 | $0 | 366,831 (Direct) |
View |
2022-08-08 Option Award |
2022-08-10 5:41 pm |
N/A 2032-08-08 |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
550,000 | $0 | 550,000 (Direct) |
View |
2022-05-01 Option Award |
2022-05-03 4:14 pm |
N/A 2025-05-01 |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
31,250 | $0 | 31,250 (Direct) |
View |
2021-08-17 Option Award |
2021-08-19 5:09 pm |
N/A 2031-08-17 |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
400,000 | $0 | 400,000 (Direct) |
View |
Ownership |
2021-03-25 9:38 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
0 | $0 | 2,105,104 (Indirect) |
View |
2020-05-21 Option Award |
2020-05-22 5:16 pm |
N/A 2030-05-20 |
MIRAGEN THERAPEUTICS INC. | MGEN | KOCH KEVIN Director |
24,000 | $0 | 24,000 (Direct) |
View |